Spotlight
Specialty
Partners
CME/CE
Gaining Ground: Expanding Options for Advanced HCC : Episode 10
Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints
Experts in liver cancer treatment provide insight on real-world trials of immune checkpoint inhibitor combinations in HCC and opine on trial endpoints when immune therapy is utilized.
EP: 1.Overview of Hepatocellular Carcinoma Risk Factors
EP: 2.Review of Curative Treatment Strategies for HCC
EP: 3.Child-Pugh Scoring System and Liver Function Assessment
EP: 4.Therapy for Locally Advanced HCC
EP: 5.The Advent of Systemic Therapy for HCC
EP: 6.Immune Checkpoint Inhibitors in HCC
EP: 7.Combination Therapy with Immune Checkpoint Inhibitors for HCC
EP: 8.IMbrave-150 and HIMALAYA: Clinical Trials of Immune Checkpoint Inhibitor Combinations in HCC
EP: 9.Immune Checkpoint Inhibitors and Their Effects on Liver Function
Now Viewing
EP: 10.Real-World Evidence on Use of Immune Checkpoint Inhibitor Combinations and Clinical Trial Endpoints
EP: 11.Novel Strategies: Combining Systemic and Local Therapies
EP: 12.HCC International Clinical Trials
Related Videos
Related Content
FDA Places Clinical Hold on Phase 1 Trial of XMT-2056 in HER2-expressing Solid Tumors
March 13th 2023
FDA Places Clinical Hold on Phase 1 Trial of XMT-2056 in HER2-expressing Solid Tumors
March 13th 2023
